DecodeME

And we demonstrated that we could.

The signals that we were seeing coming out of the research studies from UK Biobank and all of us, the Sano Gold study and DecodeME showed up in that participant population, let's call them, and that, yes, we could distinguish different mechanisms that we believed would be suitable for, in particular, drug repurposing studies where we take existing medications that are safe and well-tolerated and which we believe will give a a clinical benefit, they will help the symptoms of some of those patient subgroups and connect the dots between them.

So we did the first part of the analysis in the Mello study, and we have a new paper coming out on that, so that study's going.

It has also led us to designing with groups around the world, drug repurposing studies, which are targeted.

ME and long COVID are complex, really complex diseases.

So unfortunately, to date, there have been very few and in fact, no really reproduced genetic associations published in either long COVID or ME.

There are hints of this through the DecodeME study, the eight SNPs loci that were highlighted.

But one gene, eight genes, they don't explain the entirety of this disease.